All > Hypogonadism

kisspeptin, GnRH, naloxone for Idiopathic Hypogonadotropic Hypogonadism

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Idiopathic Hypogonadotropic Hypogonadismkisspeptin, GnRH, naloxone - Drug
Eligibility
18 - 75
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if opioid antagonists can help with idiopathic hypogonadotropic hypogonadism by looking at the subject's hypothalamic-pituitary-gonadal axis.

Eligible Conditions
  • Idiopathic Hypogonadotropic Hypogonadism

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Kisspeptin-10
1
kisspeptin 112-121
1
Kisspeptin pump

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 35 hours

35 hours
Pulse Rate
Average change in Luteinizing Hormone (LH) pulse frequency

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Similar Trials

1
Kisspeptin-10
1
kisspeptin 112-121
1
Kisspeptin pump

Trial Design

1 Treatment Group

kisspeptin, GnRH, naloxone
1 of 1

Experimental Treatment

23 Total Participants · 1 Treatment Group

Primary Treatment: kisspeptin, GnRH, naloxone · No Placebo Group · Phase 2

kisspeptin, GnRH, naloxoneExperimental Group · 3 Interventions: Naloxone, kisspeptin, GnRH, naloxone, GnRH · Intervention Types: Drug, Drug, Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Naloxone
FDA approved
Gonadorelin
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 35 hours

Who is running the clinical trial?

Stephanie B. Seminara, MDLead Sponsor
5 Previous Clinical Trials
535 Total Patients Enrolled
2 Trials studying Idiopathic Hypogonadotropic Hypogonadism
74 Patients Enrolled for Idiopathic Hypogonadotropic Hypogonadism
Stephanie Seminara, MDPrincipal InvestigatorMassachusetts General Hospital
1 Previous Clinical Trials
60 Total Patients Enrolled

Eligibility Criteria

Age 18 - 75 · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have low or low-normal levels of gonadotropins.
The patient has no abnormal pituitary or hypothalamic findings on Magnetic Resonance Imaging (MRI).
You have a thyroid stimulating hormone (TSH) and prolactin level within the reference range.
You have been diagnosed with HH.
You have no history of a medication reaction requiring emergency medical care.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top